JNJ-38877605

DB13113InvestigationalSmall molecule

JNJ-38877605 has been used in trials studying the treatment of Neoplasms.

Chemical structure of JNJ-38877605
Mechanism
Curator reviewed
Formula / weight
C19H13F2N7 · 377.359 g/mol (avg)
Code names
JNJ-38877605

Resolves to

Compound
UNII15UDG410PNCAS943540-75-8ChEMBLCHEMBL2133806ChEBI91417PubChem46911863
Structure
InChIKeyJRWCBEOAFGHNNU-UHFFFAOYSA-NSMILESCN1C=C(C=N1)C1=NN2C(C=C1)=NN=C2C(F)(F)C1=CC=C2N=CC=CC2=C1
Targets
P08581MET

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with JNJ-38877605, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In